Genenta Science tumbles 19%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Genenta Science (SAEN.US) tumbled nearly 19% during regular trading to $0.5676.

The stock is down 59.73% from its IPO price and sits 78.00% below its 52-week high of US$2.580. The intraday swing reached 12.31%.

The Nasdaq Composite is down 4.56% over the past five sessions and up 7.52% year to date.

The company received a deficiency notice from Nasdaq for failing to meet the minimum bid price requirement after its American Depositary Shares closed below the $1.00 threshold for 30 consecutive trading days.

Genenta has an initial 180-day compliance period ending April 14, 2027, to regain compliance. Shareholders have authorized a reverse stock split at a ratio between 1-for-10 and 1-for-20, which management may implement to address the deficiency. Trading will continue with no immediate delisting.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.